R-DHAOx regimen

Jump to navigation Jump to search

WikiDoc Resources for R-DHAOx regimen

Articles

Most recent articles on R-DHAOx regimen

Most cited articles on R-DHAOx regimen

Review articles on R-DHAOx regimen

Articles on R-DHAOx regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-DHAOx regimen

Images of R-DHAOx regimen

Photos of R-DHAOx regimen

Podcasts & MP3s on R-DHAOx regimen

Videos on R-DHAOx regimen

Evidence Based Medicine

Cochrane Collaboration on R-DHAOx regimen

Bandolier on R-DHAOx regimen

TRIP on R-DHAOx regimen

Clinical Trials

Ongoing Trials on R-DHAOx regimen at Clinical Trials.gov

Trial results on R-DHAOx regimen

Clinical Trials on R-DHAOx regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-DHAOx regimen

NICE Guidance on R-DHAOx regimen

NHS PRODIGY Guidance

FDA on R-DHAOx regimen

CDC on R-DHAOx regimen

Books

Books on R-DHAOx regimen

News

R-DHAOx regimen in the news

Be alerted to news on R-DHAOx regimen

News trends on R-DHAOx regimen

Commentary

Blogs on R-DHAOx regimen

Definitions

Definitions of R-DHAOx regimen

Patient Resources / Community

Patient resources on R-DHAOx regimen

Discussion groups on R-DHAOx regimen

Patient Handouts on R-DHAOx regimen

Directions to Hospitals Treating R-DHAOx regimen

Risk calculators and risk factors for R-DHAOx regimen

Healthcare Provider Resources

Symptoms of R-DHAOx regimen

Causes & Risk Factors for R-DHAOx regimen

Diagnostic studies for R-DHAOx regimen

Treatment of R-DHAOx regimen

Continuing Medical Education (CME)

CME Programs on R-DHAOx regimen

International

R-DHAOx regimen en Espanol

R-DHAOx regimen en Francais

Business

R-DHAOx regimen in the Marketplace

Patents on R-DHAOx regimen

Experimental / Informatics

List of terms related to R-DHAOx regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

R-DHAOx regimen refers to a regimen consisting of rituximab, dexamethasone, high-dose cytarabine (Ara-C), and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.[1]

Regimen

RRituximab

DDexamethasone

HHigh Dose

ACytarabine (Ara-C)

OxOxaliplatin

Indications

References

  1. 1.0 1.1 Machover D, Delmas-Marsalet B, Misra SC, Ulusakarya A, Gumus Y, Frénoy N; et al. (2010). "Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma". Biomed Pharmacother. 64 (2): 83–7. doi:10.1016/j.biopha.2009.11.001. PMID 20044233.